Pharmax Frutol Fish Oil Emulsions 10.1 fl oz (300 ml)

Free Shipping..
Price: 
$34.90
Average: 5 (1 vote)
Vendor Code: 
FA25-300
Brand: 
Type: 
Ingredients: 
Certifications: 

GMP

GMP Manufactured
Nutritional Information (Click image for Detailed View): 

Pharmax Frutol Fish Oil Emulsions- 10.1 fl oz (300 ml)

Product overview:
500 mg EPA and 375 mg DHA per serving size
• Helps support cognitive health and/or brain function (1)
• Helps support the development of the brain, eyes and nerves in children up to 12 years of age (2)
• Helps maintain/support cardiovascular health (3)
• Helps to reduce serum triglycerides/triacylglycerols (4)
Sourced from sardine and anchovy
• NEO-3™ natural EPA and DHA enrichment
Emulsified for enhanced absorption and
improved taste
• WisDOM-3™ proprietary emulsification process is proven in human clinical trials to
double omega-3 fatty acids bioavailability
• WisDOM-3™ also improves overall taste and increases patient compliance
ncludes added vitamins
• Includes vitamin A and C
Convenient, great-tasting liquid format
• Fruit flavoured base of orange, mango, banana and pineapple purees increases patient compliance

Additional product info:
Fish oils may improve cardiovascular health by altering lipid metabolism, inducing haemodynamic changes, decreasing arrhythmias, modulating platelet function, improving endothelial function and inhibiting inflammatory pathways (2). In fact, fish oil is recognized by the NHPD of Health Canada to help support and maintain cardiovascular health (3). Eicosapentaenoic acid (EPA; 22:5n-3) and docosahexaenoic acid (DHA; 22:6n-3) are the 2 principal omega-3 fatty acids in marine oils. Recent data from human studies showed that these 2 fatty acids have differential effects on serum lipids and lipoproteins, serum glucose (4 grams EPA), blood pressure (4 grams DHA), heart rate (4 grams DHA) and endothelial function (4). EPA and DHA alter membrane fluidity, interact with transcription factors such as PPAR and sterol regulatory element binding protein, and are substrates for enzymes including cyclooxygenase, lipoxygenase and cytochrome P450 (5). Studies also show that EPA and DHA (1.6-2.0 grams EPA and 0.9-1.2 grams DHA) found in fish oils generate bioactive lipid mediators that reduce inflammation and polymorphonuclear leukocyte recruitment in numerous inflammatory disease models (6),(7) . The independent effects of EPA and DHA are however poorly understood. While both EPA and DHA decrease TAG levels, only DHA appears to increase HDL and LDL particle size. Evidence to date also suggests that 2.8-4 grams DHA is more efficient in decreasing blood pressure, heart rate and platelet aggregation compared to EPA (8). EPA (4 gr/day), but not DHA, appears to increase fasting glucose concentrations in overweight, mildly hyperlipidemic men (9). Thus, reduction of postprandial triacylglycerol (TG) concentration may be cardioprotective. Studies have shown that chronic omega-3 fatty acid supplementation (4 grams of either EPA or DHA) significantly lowers postprandial TG concentrations regardless of the type of fat in test meal (10).
EPA and DHA are also crucial to brain development and normal brain functioning. DHA is particularly important to brain functioning due to its influence on neural membrane properties, which modulate cell signalling. DHA concentration in the brain decreases with age in humans and this has been postulated to be consequential to the age-related deterioration in central nervous system functions (11). Fish oil supplementation supports the development of the brain, eyes and nerves in children up to 12 years of age and helps support cognitive health and brain function (12).
Mixtures of oils (comprising: concentrated fish oil 43%, borage oil 31% and flaxseed oil 26%) in both the
natural form and in the emulsified form were evaluated in a randomised, cross-over study. 13 volunteers received the oil mixture and 11 volunteers received the oil emulsion as part of an otherwise fat free meal. Pre-emulsification of an oil mixture prior to ingestion increases the absorption of longer chain more highly unsaturated fatty acids (especially eicosapentaenoic acid and docosahexaenoic acid) but does not affect absorption of shorter chain less saturated fatty acids, suggesting that pre-emulsification of fish oils may be a useful means of boosting absorption of these beneficial fatty acids (13).

References:
2 Cottin SC, Sanders TA, Hall WL. The differential effects of EPA and DHA on cardiovascular risk factors. Proc Nutr Soc. 2011 May;70(2):215-31. Abstract
3 NHPD Monograph on Fish Oil. March 2009.
4 Woodman RJ, Mori TA, Burke V, Puddey IB, Watts GF, Beilin LJ. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr. 2002 Nov;76(5):1007-15. Page 1007, Introduction
5 Cottin SC, Sanders TA, Hall WL. The differential effects of EPA and DHA on cardiovascular risk factors. Proc Nutr Soc. 2011 May;70(2):215-31. Abstract; Page 225 Conclusion
6 McDaniel, J.C., Massey, K. and Nicolaou, A. Fish oil supplementation alters levels of lipid mediators of inflammation in microenvironment of acute human wounds. Wound Repair Regen. 2011 Mar-Apr;19(2):189-200. Page 189, Abstract & Introduction
7 van der Meij, B.S., Langius, J.A., Smit, E.F., Spreeuwenberg, M.D., von Blomberg, B.M., Heijboer, A.C., Paul, M.A. and van Leeuwen, P.A. Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment . J Nutr. 2010 Oct;140(10):1774-80. Page 1775, 2nd paragraph
8 Cottin SC, Sanders TA, Hall WL. The differential effects of EPA and DHA on cardiovascular risk factors. Proc Nutr Soc. 2011 May;70(2):215-31. Abstract; Page 225 Conclusion
9 Woodman RJ, Mori TA, Burke V, Puddey IB, Watts GF, Beilin LJ. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr. 2002 Nov;76(5):1007-15. Page 1007, Introduction
10 Park, Y. and Harris, W.S. Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance. J Lipid Res. 2003 Mar;44(3):455-63. Page 455, Introduction
11 Danthiir V, Burns NR, Nettelbeck T, Wilson C, Wittert G. The Older People, Omega-3, and Cognitive Health (EPOCH) trial design and methodology: A randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy older adults. Nutr J. 2011 Oct 20;10(1):117. Page 2, Background, 2nd paragraph
12 NHPD Monograph on Fish Oil. March 2009.
13 Garaiova I, Guschina IA, Plummer SF, Tang J, Wang D, Plummer NT. A randomised cross-over trial in healthy adults indicating improved absorption of omega-3 fatty acids by pre-emulsification. Nutr J. 2007 Jan 25;6:4. Page 1, Abstract; Page 2, Study Design and Diet, 2nd paragraph

Other ingredients: Concentrated pineapple and orange juices, modified corn starch, purified water, fructose, mango and banana purees, hydroxypropyl alginate, ascorbic acid, pineapple and vanilla flavors, acacia gum, natural mixed tocopherols, potassium sorbate

Pharmax